BlackRock Q4 Profit Rises 6%, Tops Estimates; Boosts Dividend 18% - Quick Facts

BlackRock, Inc. (BLK) reported that its fourth-quarter net income increased to $1.64 billion or $10.63 per share from $1.55 billion or $10.02 per share in the year-ago quarter.

Excluding items, adjusted net income for the quarter was $1.61 billion or $10.42 per share, compared to $1.57 billion or $10.18 per share in the prior-year quarter.

Total revenue for the quarter increased 14 percent to $5.11 billion from $4.48 billion in the same quarter last year.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $10.15 per share on revenues to $5.17 billion for the quarter. Analysts' estimates typically exclude special items.

BlackRock's Board of Directors also approved an 18% increase in the quarterly cash dividend to $4.88 per share, payable March 23, 2022, to shareholders of record at the close of business on March 7, 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT